Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNITED THERAPEUTICS Corp Director's Dealing 2012

Aug 3, 2012

30320_dirs_2012-08-03_2b5ebb05-9645-4b22-9f87-849c542f5075.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2012-08-02

Reporting Person: Ferrari John Maxim (CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-02 Common Stock M 5500 $25.315 Acquired 5500 Direct
2012-08-02 Common Stock S 5500 $53.75 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-02 Share Tracking Award $25.315 M 5500 Disposed 2018-09-15 Common Stock (5500) Direct

Footnotes

F1: Exercise of a cash-settled share tracking award.

F2: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.

F3: Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.